Purchase Order 75N95023P00824
Award Date 9/22/23
Potential Completion Date 9/20/25
Potential Value $249K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
La Jolla, CA 92037, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the development of a conditional knockout mouse line to support NICHD's research. The total ceiling value of the contract is $14,380.00 with a completion date of January 5, 2024. There is no set-aside...
- This is a firm fixed price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the delivery of specialized Kremen1-flox mice, which are a type of knockout mouse model, to support preclinical drug discovery and development research. The contract has a ceiling value of $13,509.55 and a completion date of November 19,...
- This is a firm-fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the delivery of conditional knockout mouse lines to support NICHD's research programs. The total ceiling value of the contract is $11,930, and the period of performance is through January 15, 2023....
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a part of the National Institutes of Health (NIH), to Gempharmatech LLC, a biotechnology company that specializes in developing humanized animal models. The contract is for the provision of a conditional knock-out mouse line to support NICHD's research. The contract has a ceiling value of $17,225 and a period of performance ending on August 31, 2022. Gempharmatech LLC has...
- This contract award to Gempharmatech LLC, a foreign-owned biotechnology company in San Diego, California, is for a $58,936 fixed-price purchase order to evaluate the safety of the compound YC1 in mice with humanized SULT1A1 proteins versus standard mouse SULT1A1 proteins. The contract was awarded by the National Center for Advancing Translational Sciences (NCATS), which operates under the National Institutes of Health within the Department of Health and Human Services. The objective is to...
- This is a firm fixed-price federal contract award from the Veterans Integrated Service Network 12, a civilian agency, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the generation of PGP/MDR1A floxed live mice, a specialized mouse model, to support preclinical drug discovery and development research. The contract has a ceiling value of $13,509.55 and a completion date of March 14, 2025. Gempharmatech has previously received similar contract awards...
- This is a $35,600 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Pharmaron, Inc., a minority-owned for-profit organization, to conduct a mouse study evaluating NNMT inhibitors in high grade serous ovarian cancer. The work, which has a 12-month period of performance, involves formulating compounds, developing a mouse model, conducting efficacy studies, and analyzing samples. No set-aside...
- This is a $18,243.50 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Cyagen Biomodels LLC, a for-profit biotechnology company in Santa Clara, California. The contract is for laboratory research to generate a mouse YWHAE (N terminal-EGFP) knockin project on a C57BL/6J genetic background. This specialized genetic engineering service supports advanced scientific investigations across multiple...
- This is a $19,206 firm-fixed price purchase order awarded by the Office of Logistics and Acquisition Operations, part of the National Institutes of Health (NIH), to the Board of Regents of the University of Nebraska, doing business as the University of Nebraska Medical Center (UNMC). The contract is for UNMC to generate two CRISPR-EASI transgenic mice for the National Institute on Deafness and Other Communication Disorders (NIDCD). UNMC was selected on a sole-source basis as the only facility...
- This is a $35,160 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Ozgene PTY LTD, an Australian company, for the generation of a THRB-Cre-ERT2 knock-in mouse model. The work involves designing and constructing a targeting vector, selecting recombinant embryonic stem cell clones, and generating founder mice carrying the...